Comparative Analysis of WBC-Derived Inflammatory Markers in Cavitary and Non-Cavitary Sputum-Positive Tuberculosis

Authors

  • Swathy Moorthy MD (General Medicine), Professor, Department of General Medicine, Sri Ramachandra Institute of Higher Education and Research, Porur, Chennai, Tamil Nadu, India, 600116. orcid https://orcid.org/0000-0003-0981-6551
  • Emmanuel Bhaskar MD (General Medicine), Professor, Department of General Medicine, Sri Ramachandra Institute of Higher Education and Research, Porur, Chennai, Tamil Nadu, India, 600116. orcid https://orcid.org/0000-0002-3524-641X
  • Shivakumar S MD (General Medicine), Honorary Physician, Department of Medicine, Railway Hospital, Perumbur, Chennai 600023. Medical Director, Madras Institute of Magnetobiology, Anna Nagar, Chennai 600040. orcid https://orcid.org/0009-0006-0753-1076
  • Santhi SIlambanan MD (Biochemistry), Professor, Department of Biochemistry, Sri Ramachandra Institute of Higher Education and Research, Porur, Chennai, Tamil Nadu, India, 600116. orcid https://orcid.org/0000-0003-0720-6063

DOI:

https://doi.org/10.22100/ijhs.v11i4.1252

Keywords:

inflammation, Tuberculosis, diagnosis, cavitatory, non-cavitatory

Abstract

Background: Tuberculosis (TB), as an infectious disease, has consistently topped the list in any discussions owing to its spectrum of manifestations, morbidity, and mortality. The current diagnostic procedures are time consuming and cumbersome. Hence, there has been a constant search for highly sensitive and specific biomarkers with less turn-around-time as well as maintaining sensitivity and specificity. The current study aimed to examine the role of WBC and their derived inflammatory markers in sputum-positive active pulmonary tuberculosis (PTB) patients with and without cavity.

Methods: The study was conducted among sputum-positive PTB patients (n=27) who were further grouped into cavitatory (n=15) and non-cavitatory (n=12). The presence of cavities in the lungs were identified by chest X-ray. The study was conducted in the Department of General Medicine at a tertiary hospital in South India. Ethics approval was obtained from the institutional ethics committee (IEC), and written informed consent was obtained before the patients were inducted into the study. The various WBC-derived ratios were calculated from the data collected and compared between the two subgroup populations as indicative of their inflammation and prognosis. Statistics were performed using SPSS software version 16. P-value≤0.05 was considered statistically significant.

Results: The tuberculous patients with cavity were younger, and the absolute neutrophil counts (ANC), liver enzymes aspartate aminotransferase (AST) and alanine aminotransferase (ALT), were significantly higher among the cavitatory group compared to noncavitatory group. Comparing inflammation between the groups showed statistically significant differences between the cavitatory and the non-cavitatory groups in most of the WBC-derived ratios.

Conclusions: Most of the inflammatory indices serve as easy and inexpensive biomarkers. Their prognostic value allows risk stratification among PTB patients. These markers can be used to predict the outcomes as well as assess the response to treatment.

References

Khojasteh-Kaffash S, Habibzadeh A, Moghaddam S, Afra F, Samieefar N, Fateh A. Tuberculosis Trends in the Post-COVID-19 Era: Is It Going to be a Global Concern? Health Sci Rep. 2025 May 21;8(5): e70792. doi: 10.1002/hsr2.70792

Chakaya J, Khan M, Ntoumi F, Aklillu E, Fatima R, Mwaba P, et al. Global Tuberculosis Report 2020-Reflections on the Global TB burden, treatment and prevention efforts. International journal of infectious diseases. 2021 Dec 1;113: S7-12. doi: 10.1016/j.ijid.2021.02.107

Nguyen HV, Brals D, Tiemersma E, Gasior R, Nguyen NV, Nguyen HB, et al. Influence of sex and sex-based disparities on prevalent tuberculosis, Vietnam, 2017-2018. Emerging Infectious Diseases. 2023 May;29(5):967. doi: 10.3201/eid2905.221476

Yayan J, Franke KJ, Berger M, Windisch W, Rasche K. Early detection of tuberculosis: a systematic review. Pneumonia (Nathan). 2024 Jul 5;16(1):11. doi: 10.1186/s41479-024-00133-z

Chan SH, Yu T, Zhang Z, Chang LY, Guo C, Bo Y, et al. Total and differential white blood cell count and cause-specific mortality in 436 750 Taiwanese adults. Nutrition, Metabolism and Cardiovascular Diseases. 2022 Apr 1;32(4):937-47. doi: 10.1016/j.numecd.2021.11.004

Chai B, Wu D, Fu N, Huang P, Shen Y, Li Y, et al. Evaluation of prognostic inflammatory and systemic inflammatory response indices in auxiliary diagnosis of bacteria-negative pulmonary tuberculosis: A diagnostic accuracy study. Medicine (Baltimore). 2023 Mar 24;102(12): e33372. doi: 10.1097/MD.0000000000033372

Omair M, Baig MS, Farooqui WA, Kousar S, Noori MY, Zeehan N, et al. Relationship of neutrophil lymphocyte ratio, monocyte lymphocyte ratio and neutrophil monocyte ratio with treatment response in pulmonary tuberculosis patients during intensive phase treatment. BMC Infect Dis. 2024 Jun 21;24(1):615. doi: 10.1186/s12879-024-09454-2

Gholoobi A, Masoudi-Kazemabad A, Meshkat M, Meshkat Z. Comparison of culture and PCR methods for diagnosis of Mycobacterium tuberculosis in different clinical specimens. Jundishapur J Microbiol. 2014;7: e8939. doi: 10.5812/jjm.8939

An HR, Bai XJ, Liang JQ, Wang T, Wang ZY, Xue Y, et al. The relationship between absolute counts of lymphocyte subsets and clinical features in patients with pulmonary tuberculosis. Clin Respir J. 2022 May;16(5):369-379. doi: 10.1111/crj.13490

Yoon NB, Son C, Um SJ. Role of the neutrophil-lymphocyte count ratio in the differential diagnosis between pulmonary tuberculosis and bacterial community-acquired pneumonia. Ann Lab Med. 2013;33(2):105-110. doi: 10.3343/alm.2013.33.2.105

Chen G, Wu C, Luo Z, Teng Y, Mao S. Platelet-lymphocyte ratios: a potential marker for pulmonary tuberculosis diagnosis in COPD patients. Int J Chron Obstruct Pulmon Dis. 2016 Nov 3; 11:2737-2740. doi: 10.2147/COPD.S111254

Xia Y, Xia C, Wu L, Li Z, Li H, Zhang J. Systemic Immune Inflammation Index (SII), System Inflammation Response Index (SIRI) and Risk of All-Cause Mortality and Cardiovascular Mortality: A 20-Year Follow-Up Cohort Study of 42,875 US Adults. J Clin Med. 2023 Jan 31;12(3):1128. doi: 10.3390/jcm12031128

Ma X, Yang J, Wang X, Wang X, Chai S. The Clinical Value of Systemic Inflammatory Response Index and Inflammatory Prognosis Index in Predicting 3-Month Outcome in Acute Ischemic Stroke Patients with Intravenous Thrombolysis. Int J Gen Med. 2022 Oct 22; 15:7907-7918. doi: 10.2147/IJGM.S384706

Jiang Y, Luo B, Lu W, Chen Y, Peng Y, Chen L, et al. Association Between the Aggregate Index of Systemic Inflammation and Clinical Outcomes in Patients with Acute Myocardial Infarction: A Retrospective Study. J Inflamm Res. 2024 Oct 3; 17:7057-7067. doi: 10.2147/JIR.S481515

Sarma AK, Das A, Thakuria B, Saikia P. C-reactive Protein to Albumin Ratio as a Predictor of Infectious Etiology in Patients Admitted to General Medicine: A Single-center Prospective Observational Study. Archives of Medicine and Health Sciences. 2024 Sep 1;12(3):329-34. doi: 10.4103/amhs.amhs_179_23

Ao T, Huang Y, Zhen P, Hu M. Association Between C-Reactive Protein to Lymphocyte Ratio and Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study. Int J Chron Obstruct Pulmon Dis. 2025 Jun 12; 20:1915-1925. doi: 10.2147/COPD.S510755

Nalbant A, Demirci T, Kaya T, Aydın A, Altındiş M, Güçlü E. Can prognostic nutritional index and systemic immune-inflammatory index predict disease severity in COVID-19? Int J Clin Pract. 2021 Oct;75(10): e14544. doi: 10.1111/ijcp.14544

Bloom BR, Atun R, Cohen T, et al. Tuberculosis. In: Holmes KK, Bertozzi S, Bloom BR, et al., editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. Available from: https://www.ncbi.nlm.nih.gov/books/NBK525174/

Mayer-Barber KD, Barber DL. Innate and Adaptive Cellular Immune Responses to Mycobacterium tuberculosis Infection. Cold Spring Harb Perspect Med. 2015 Jul 17;5(12): a018424. doi: 10.1101/cshperspect.a018424

Lee KM, Choe KH, Kim SJ. Clinical investigation of cavitary tuberculosis and tuberculous pneumonia. Korean J Intern Med. 2006 Dec;21(4):230-5. doi: 10.3904/kjim.2006.21.4.230

Zhang L, Pang Y, Yu X, Wang Y, Lu J, Gao M, et al. Risk factors for pulmonary cavitation in tuberculosis patients from China. Emerg Microbes Infect. 2016 Oct 12;5(10): e110. doi: 10.1038/emi.2016.111

Tverdal A. Body mass index and incidence of tuberculosis. Eur J Respir Dis. 1986 Nov;69(5):355-62. PMID: 3792471

Cegielski JP, McMurray DN. Tuberculosis: Nutrition and Susceptibility. In: Caballero B, Allen L, Prentice A, editors. Encyclopedia of Human Nutrition, 2nd ed (4 Vol Set). Oxford: Elsevier, 2005:289-290. ISBN: 9780121501105

Selvan P, Nagesh NJ, Vajravelu LK. Influence of Anemia on the Prognosis of Patients with Tuberculosis: An Indicator of Severity. J Pure Appl Microbiol. 2025;19(1):669-681. doi: 10.22207/JPAM.19.1.56

Gautam S, Sigdel KR, Adhikari S, Basnyat B, Paudyal B, Poudel J, et al. Case Report: Pulmonary tuberculosis and raised transaminases without pre-existing liver disease- Do we need to modify the antitubercular therapy? Wellcome Open Res. 2020 Oct 16; 5:193. doi: 10.12688/wellcomeopenres.16175.2

Okamura K, Nagata N, Wakamatsu K, Yonemoto K, Ikegame S, Kajiki A, et al. Hypoalbuminemia and lymphocytopenia are predictive risk factors for in-hospital mortality in patients with tuberculosis. Intern Med. 2013;52(4):439-44. doi: 10.2169/internalmedicine.52.8158

Shah AR, Desai KN, Maru AM. Evaluation of hematological parameters in pulmonary tuberculosis patients. J Family Med Prim Care. 2022 Aug;11(8):4424-4428. doi: 10.4103/jfmpc.jfmpc_2451_21

Shaikh MK, Samo JA, Devrajani BR, Shah SZ, Shaikh S, Shaikh I. C-reactive protein in patients with pulmonary tuberculosis. World Applied Sciences Journal. 2012 Jun 6;17(2):140-144.

Chen G, Wu C, Luo Z, Teng Y, Mao S. Platelet-lymphocyte ratios: a potential marker for pulmonary tuberculosis diagnosis in COPD patients. Int J Chron Obstruct Pulmon Dis. 2016 Nov 3; 11:2737-2740. doi: 10.2147/COPD.S111254

Wang RH, Wen WX, Jiang ZP, et al. The clinical value of neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), platelet-to-lymphocyte ratio (PLR) and systemic inflammation response index (SIRI) for predicting the occurrence and severity of pneumonia in patients with intracerebral hemorrhage. Front Immunol. 2023; 14:1115031. doi: 10.3389/fimmu.2023.1115031

Islam MM, Satici MO, Eroglu SE. Unraveling the clinical significance and prognostic value of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic immune-inflammation index, systemic inflammation response index, and delta neutrophil index: An extensive literature review. Turk J Emerg Med. 2024;24(1):8-19. doi: 10.4103/tjem.tjem_198_23

Yu Z, Shang Z, Huang Q, Wen F, Patil S. Integrating systemic immune-inflammation index, fibrinogen, and T-SPOT.TB for precision distinction of active pulmonary tuberculosis in the era of mycobacterial disease research. Front Microbiol. 2024 Apr 25; 15:1382665. doi: 10.3389/fmicb.2024.1382665

Gremese E, Bruno D, Varriano V, Perniola S, Petricca L, Ferraccioli G. Serum Albumin Levels: A Biomarker to Be Repurposed in Different Disease Settings in Clinical Practice. J Clin Med. 2023 Sep 17;12(18):6017. doi: 10.3390/jcm12186017

Zinellu A, Collu C, Nasser M, Paliogiannis P, Mellino S, Zinellu E, et al. The Aggregate Index of Systemic Inflammation (AISI): A Novel Prognostic Biomarker in Idiopathic Pulmonary Fibrosis. J Clin Med. 2021 Sep 14;10(18):4134. doi: 10.3390/jcm10184134

Hu S, Yu Q, Liu F, Gong F. A Novel Inflammatory Indicator for Tuberculosis-Associated Obstructive Pulmonary Disease (TOPD): The Systemic Inflammatory Response Index (SIRI). J Inflamm Res. 2024 Jul 2; 17:4219-4228. doi: 10.2147/JIR.S468232

Mara G, Nini G, Frenț SM, Cotoraci C. Hematologic and Immunologic Overlap Between COVID-19 and Idiopathic Pulmonary Fibrosis. J Clin Med. 2025 Jul 24;14(15):5229. doi: 10.3390/jcm14155229

Park JE, Chung KS, Song JH, Kim SY, Kim EY, Jung JY, et al. The C-Reactive Protein/Albumin Ratio as a Predictor of Mortality in Critically Ill Patients. J Clin Med. 2018 Oct 8;7(10):333. doi: 10.3390/jcm7100333

Fairclough E, Cairns E, Hamilton J, Kelly C. Evaluation of a modified early warning system for acute medical admissions and comparison with C-reactive protein/albumin ratio as a predictor of patient outcome. Clin Med (Lond). 2009 Feb;9(1):30-3. doi: 10.7861/clinmedicine.9-1-30

Luan YY, Yao YM. The Clinical Significance and Potential Role of C-Reactive Protein in Chronic Inflammatory and Neurodegenerative Diseases. Front Immunol. 2018 Jun 7; 9:1302. doi: 10.3389/fimmu.2018.01302

Cao LY, Cheng S, Lin L, Chen MX. Effect of Controlling Nutritional Status Score (CONUT) and Prognostic Nutritional Index (PNI) on patients after spinal tuberculosis surgery. Scientific Reports. 2022 Sep 26;12(1):16056. doi: 10.1038/s41598-022-19345-8

Downloads

Published

2025-10-18

Issue

Section

Articles

How to Cite

Comparative Analysis of WBC-Derived Inflammatory Markers in Cavitary and Non-Cavitary Sputum-Positive Tuberculosis. (2025). Shahroud Journal of Medical Sciences, 11(4), 18-26. https://doi.org/10.22100/ijhs.v11i4.1252